Menu Close

Northwestern Mutual Wealth Management Co. Purchases 1,738 Shares of Agilent Technologies, Inc. (NYSE:A)

Northwestern Mutual Wealth Management Co. boosted its stake in Agilent Technologies, Inc. (NYSE:AGet Rating) by 148.9% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,905 shares of the medical research company’s stock after buying an additional 1,738 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Agilent Technologies were worth $385,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BlackRock Inc. raised its stake in shares of Agilent Technologies by 6.8% during the fourth quarter. BlackRock Inc. now owns 29,352,219 shares of the medical research company’s stock valued at $4,686,082,000 after acquiring an additional 1,879,602 shares during the last quarter. State Street Corp grew its holdings in Agilent Technologies by 3.1% in the fourth quarter. State Street Corp now owns 13,370,324 shares of the medical research company’s stock worth $2,134,572,000 after purchasing an additional 401,106 shares during the period. Geode Capital Management LLC grew its holdings in Agilent Technologies by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 5,866,133 shares of the medical research company’s stock worth $934,437,000 after purchasing an additional 103,871 shares during the period. Pictet Asset Management SA grew its holdings in shares of Agilent Technologies by 3.0% during the fourth quarter. Pictet Asset Management SA now owns 4,752,712 shares of the medical research company’s stock valued at $758,770,000 after buying an additional 138,793 shares during the last quarter. Finally, Impax Asset Management Group plc grew its holdings in shares of Agilent Technologies by 13.6% during the fourth quarter. Impax Asset Management Group plc now owns 4,540,510 shares of the medical research company’s stock valued at $724,892,000 after buying an additional 544,288 shares during the last quarter.

Agilent Technologies Price Performance

NYSE A opened at $133.94 on Tuesday. Agilent Technologies, Inc. has a 12 month low of $112.52 and a 12 month high of $179.57. The stock has a market cap of $40.01 billion, a price-to-earnings ratio of 30.51, a PEG ratio of 2.71 and a beta of 1.06. The company’s 50 day moving average is $124.63 and its two-hundred day moving average is $127.40. The company has a current ratio of 1.94, a quick ratio of 1.41 and a debt-to-equity ratio of 0.54.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings data on Tuesday, August 16th. The medical research company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. The business had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the firm posted $1.10 EPS. The company’s revenue was up 8.3% on a year-over-year basis. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 5.07 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have commented on A shares. Wells Fargo & Company lifted their price objective on shares of Agilent Technologies from $130.00 to $135.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 17th. Evercore ISI boosted their price objective on shares of Agilent Technologies to $145.00 in a report on Monday. UBS Group assumed coverage on shares of Agilent Technologies in a report on Wednesday, July 20th. They issued a “buy” rating and a $139.00 price objective for the company. Bank of America upped their price target on shares of Agilent Technologies from $148.00 to $155.00 and gave the company a “buy” rating in a report on Wednesday, August 17th. Finally, Citigroup upped their target price on shares of Agilent Technologies from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 17th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $150.17.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Jacob Thaysen sold 5,879 shares of Agilent Technologies stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the transaction, the vice president now directly owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Agilent Technologies news, VP Jacob Thaysen sold 5,879 shares of the business’s stock in a transaction that occurred on Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total value of $749,160.97. Following the completion of the transaction, the vice president now directly owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Padraig Mcdonnell sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total value of $118,620.00. Following the completion of the transaction, the vice president now directly owns 17,826 shares of the company’s stock, valued at $2,114,520.12. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AGet Rating).

Receive News & Ratings for Agilent Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.